The global Adult Immune Cell Storage market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Immune cell storage refers to the use of biotechnology to extract a certain number of healthy immune cells from the human body. After testing and identification, they are stored in deep-temperature liquid nitrogen tanks at -150掳C to -196掳C to maintain the activity of immune cells for a long time, is a functional kind of business. Immune cell banking utilizes healthy cells to treat diseased cells, such as cancer cells. Immune cells can specifically scan the body for mutations that may be linked to cancer. When they do find these mutations, the cells work to eliminate them. Immune cells are an important line of defense for the human body to resist the invasion of foreign substances and eliminate aging, mutated, and cancerous cells. Human immunity reaches its peak at the age of 20. With age, environmental deterioration, bad living habits and other factors, the number of immune cells and Quality continues to decline and incidence rates gradually increase. When the body is in good condition, immune cells are stored in advance and health assets are proactively managed.
Immunotherapy is an emerging treatment method that uses a patient"s own immune cells to fight life-threatening diseases such as cancer. This is important because the average person"s chance of developing cancer in their lifetime is about 33 percent and increases with age. As of 2023, there are currently at least 6 FDA-approved cellular immunotherapies for cancer treatment, with more being investigated every day.
The 鈥淎dult Immune Cell Storage Industry Forecast鈥� looks at past sales and reviews total world Adult Immune Cell Storage sales in 2024, providing a comprehensive analysis by region and market sector of projected Adult Immune Cell Storage sales for 2025 through 2031. With Adult Immune Cell Storage sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Adult Immune Cell Storage industry.
This Insight Report provides a comprehensive analysis of the global Adult Immune Cell Storage landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Adult Immune Cell Storage portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Adult Immune Cell Storage market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Adult Immune Cell Storage and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Adult Immune Cell Storage.
This report presents a comprehensive overview, market shares, and growth opportunities of Adult Immune Cell Storage market by product type, application, key players and key regions and countries.
Segmentation by Type:
NK Cells
T cells
B Cells
Segmentation by Application:
Adjuvant Treatment for Cancer
Anti Aging Treatment
Regulate Sub-Health
Prevention
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
HealthBanks
Aeterna Health
Cell Vault
Redermis
Innovita Research
STEMCELL
Enhance Biomedical
Immunaeon
Miracell
Maharaj Institute
FullHope Biomedical
Ivy Life Sciences
Vectorite Biomedical
Zhong Ji 1 International Medical
OrganaBio
VCANBIO
Beike Biotechnology
H&B
Shanghai Cell Therapy Group
BGI CELL
ICELL
SALIAI
S-Evans Biosciences
Zhengda Stem Cell Bank
Liaoning Huize Health Biotech
Supercell Biotechnology
Guangxi Academy of Sciences Cell Bank
Bailing Stem Cell
Retain Biotech
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Adult Immune Cell Storage 麻豆原创 Size (2020-2031)
2.1.2 Adult Immune Cell Storage 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Adult Immune Cell Storage by Country/Region (2020, 2024 & 2031)
2.2 Adult Immune Cell Storage Segment by Type
2.2.1 NK Cells
2.2.2 T cells
2.2.3 B Cells
2.3 Adult Immune Cell Storage 麻豆原创 Size by Type
2.3.1 Adult Immune Cell Storage 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Adult Immune Cell Storage 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Adult Immune Cell Storage Segment by Application
2.4.1 Adjuvant Treatment for Cancer
2.4.2 Anti Aging Treatment
2.4.3 Regulate Sub-Health
2.4.4 Prevention
2.4.5 Others
2.5 Adult Immune Cell Storage 麻豆原创 Size by Application
2.5.1 Adult Immune Cell Storage 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Adult Immune Cell Storage 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Adult Immune Cell Storage 麻豆原创 Size by Player
3.1 Adult Immune Cell Storage 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Adult Immune Cell Storage Revenue by Player (2020-2025)
3.1.2 Global Adult Immune Cell Storage Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Adult Immune Cell Storage Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Adult Immune Cell Storage by Region
4.1 Adult Immune Cell Storage 麻豆原创 Size by Region (2020-2025)
4.2 Global Adult Immune Cell Storage Annual Revenue by Country/Region (2020-2025)
4.3 Americas Adult Immune Cell Storage 麻豆原创 Size Growth (2020-2025)
4.4 APAC Adult Immune Cell Storage 麻豆原创 Size Growth (2020-2025)
4.5 Europe Adult Immune Cell Storage 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Adult Immune Cell Storage 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Adult Immune Cell Storage 麻豆原创 Size by Country (2020-2025)
5.2 Americas Adult Immune Cell Storage 麻豆原创 Size by Type (2020-2025)
5.3 Americas Adult Immune Cell Storage 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Adult Immune Cell Storage 麻豆原创 Size by Region (2020-2025)
6.2 APAC Adult Immune Cell Storage 麻豆原创 Size by Type (2020-2025)
6.3 APAC Adult Immune Cell Storage 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Adult Immune Cell Storage 麻豆原创 Size by Country (2020-2025)
7.2 Europe Adult Immune Cell Storage 麻豆原创 Size by Type (2020-2025)
7.3 Europe Adult Immune Cell Storage 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Adult Immune Cell Storage by Region (2020-2025)
8.2 Middle East & Africa Adult Immune Cell Storage 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Adult Immune Cell Storage 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Adult Immune Cell Storage 麻豆原创 Forecast
10.1 Global Adult Immune Cell Storage Forecast by Region (2026-2031)
10.1.1 Global Adult Immune Cell Storage Forecast by Region (2026-2031)
10.1.2 Americas Adult Immune Cell Storage Forecast
10.1.3 APAC Adult Immune Cell Storage Forecast
10.1.4 Europe Adult Immune Cell Storage Forecast
10.1.5 Middle East & Africa Adult Immune Cell Storage Forecast
10.2 Americas Adult Immune Cell Storage Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Adult Immune Cell Storage Forecast
10.2.2 Canada 麻豆原创 Adult Immune Cell Storage Forecast
10.2.3 Mexico 麻豆原创 Adult Immune Cell Storage Forecast
10.2.4 Brazil 麻豆原创 Adult Immune Cell Storage Forecast
10.3 APAC Adult Immune Cell Storage Forecast by Region (2026-2031)
10.3.1 China Adult Immune Cell Storage 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Adult Immune Cell Storage Forecast
10.3.3 Korea 麻豆原创 Adult Immune Cell Storage Forecast
10.3.4 Southeast Asia 麻豆原创 Adult Immune Cell Storage Forecast
10.3.5 India 麻豆原创 Adult Immune Cell Storage Forecast
10.3.6 Australia 麻豆原创 Adult Immune Cell Storage Forecast
10.4 Europe Adult Immune Cell Storage Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Adult Immune Cell Storage Forecast
10.4.2 France 麻豆原创 Adult Immune Cell Storage Forecast
10.4.3 UK 麻豆原创 Adult Immune Cell Storage Forecast
10.4.4 Italy 麻豆原创 Adult Immune Cell Storage Forecast
10.4.5 Russia 麻豆原创 Adult Immune Cell Storage Forecast
10.5 Middle East & Africa Adult Immune Cell Storage Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Adult Immune Cell Storage Forecast
10.5.2 South Africa 麻豆原创 Adult Immune Cell Storage Forecast
10.5.3 Israel 麻豆原创 Adult Immune Cell Storage Forecast
10.5.4 Turkey 麻豆原创 Adult Immune Cell Storage Forecast
10.6 Global Adult Immune Cell Storage Forecast by Type (2026-2031)
10.7 Global Adult Immune Cell Storage Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Adult Immune Cell Storage Forecast
11 Key Players Analysis
11.1 HealthBanks
11.1.1 HealthBanks Company Information
11.1.2 HealthBanks Adult Immune Cell Storage Product Offered
11.1.3 HealthBanks Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 HealthBanks Main Business Overview
11.1.5 HealthBanks Latest Developments
11.2 Aeterna Health
11.2.1 Aeterna Health Company Information
11.2.2 Aeterna Health Adult Immune Cell Storage Product Offered
11.2.3 Aeterna Health Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Aeterna Health Main Business Overview
11.2.5 Aeterna Health Latest Developments
11.3 Cell Vault
11.3.1 Cell Vault Company Information
11.3.2 Cell Vault Adult Immune Cell Storage Product Offered
11.3.3 Cell Vault Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Cell Vault Main Business Overview
11.3.5 Cell Vault Latest Developments
11.4 Redermis
11.4.1 Redermis Company Information
11.4.2 Redermis Adult Immune Cell Storage Product Offered
11.4.3 Redermis Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Redermis Main Business Overview
11.4.5 Redermis Latest Developments
11.5 Innovita Research
11.5.1 Innovita Research Company Information
11.5.2 Innovita Research Adult Immune Cell Storage Product Offered
11.5.3 Innovita Research Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Innovita Research Main Business Overview
11.5.5 Innovita Research Latest Developments
11.6 STEMCELL
11.6.1 STEMCELL Company Information
11.6.2 STEMCELL Adult Immune Cell Storage Product Offered
11.6.3 STEMCELL Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 STEMCELL Main Business Overview
11.6.5 STEMCELL Latest Developments
11.7 Enhance Biomedical
11.7.1 Enhance Biomedical Company Information
11.7.2 Enhance Biomedical Adult Immune Cell Storage Product Offered
11.7.3 Enhance Biomedical Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Enhance Biomedical Main Business Overview
11.7.5 Enhance Biomedical Latest Developments
11.8 Immunaeon
11.8.1 Immunaeon Company Information
11.8.2 Immunaeon Adult Immune Cell Storage Product Offered
11.8.3 Immunaeon Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Immunaeon Main Business Overview
11.8.5 Immunaeon Latest Developments
11.9 Miracell
11.9.1 Miracell Company Information
11.9.2 Miracell Adult Immune Cell Storage Product Offered
11.9.3 Miracell Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Miracell Main Business Overview
11.9.5 Miracell Latest Developments
11.10 Maharaj Institute
11.10.1 Maharaj Institute Company Information
11.10.2 Maharaj Institute Adult Immune Cell Storage Product Offered
11.10.3 Maharaj Institute Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Maharaj Institute Main Business Overview
11.10.5 Maharaj Institute Latest Developments
11.11 FullHope Biomedical
11.11.1 FullHope Biomedical Company Information
11.11.2 FullHope Biomedical Adult Immune Cell Storage Product Offered
11.11.3 FullHope Biomedical Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 FullHope Biomedical Main Business Overview
11.11.5 FullHope Biomedical Latest Developments
11.12 Ivy Life Sciences
11.12.1 Ivy Life Sciences Company Information
11.12.2 Ivy Life Sciences Adult Immune Cell Storage Product Offered
11.12.3 Ivy Life Sciences Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Ivy Life Sciences Main Business Overview
11.12.5 Ivy Life Sciences Latest Developments
11.13 Vectorite Biomedical
11.13.1 Vectorite Biomedical Company Information
11.13.2 Vectorite Biomedical Adult Immune Cell Storage Product Offered
11.13.3 Vectorite Biomedical Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Vectorite Biomedical Main Business Overview
11.13.5 Vectorite Biomedical Latest Developments
11.14 Zhong Ji 1 International Medical
11.14.1 Zhong Ji 1 International Medical Company Information
11.14.2 Zhong Ji 1 International Medical Adult Immune Cell Storage Product Offered
11.14.3 Zhong Ji 1 International Medical Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Zhong Ji 1 International Medical Main Business Overview
11.14.5 Zhong Ji 1 International Medical Latest Developments
11.15 OrganaBio
11.15.1 OrganaBio Company Information
11.15.2 OrganaBio Adult Immune Cell Storage Product Offered
11.15.3 OrganaBio Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 OrganaBio Main Business Overview
11.15.5 OrganaBio Latest Developments
11.16 VCANBIO
11.16.1 VCANBIO Company Information
11.16.2 VCANBIO Adult Immune Cell Storage Product Offered
11.16.3 VCANBIO Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 VCANBIO Main Business Overview
11.16.5 VCANBIO Latest Developments
11.17 Beike Biotechnology
11.17.1 Beike Biotechnology Company Information
11.17.2 Beike Biotechnology Adult Immune Cell Storage Product Offered
11.17.3 Beike Biotechnology Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Beike Biotechnology Main Business Overview
11.17.5 Beike Biotechnology Latest Developments
11.18 H&B
11.18.1 H&B Company Information
11.18.2 H&B Adult Immune Cell Storage Product Offered
11.18.3 H&B Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 H&B Main Business Overview
11.18.5 H&B Latest Developments
11.19 Shanghai Cell Therapy Group
11.19.1 Shanghai Cell Therapy Group Company Information
11.19.2 Shanghai Cell Therapy Group Adult Immune Cell Storage Product Offered
11.19.3 Shanghai Cell Therapy Group Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 Shanghai Cell Therapy Group Main Business Overview
11.19.5 Shanghai Cell Therapy Group Latest Developments
11.20 BGI CELL
11.20.1 BGI CELL Company Information
11.20.2 BGI CELL Adult Immune Cell Storage Product Offered
11.20.3 BGI CELL Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 BGI CELL Main Business Overview
11.20.5 BGI CELL Latest Developments
11.21 ICELL
11.21.1 ICELL Company Information
11.21.2 ICELL Adult Immune Cell Storage Product Offered
11.21.3 ICELL Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 ICELL Main Business Overview
11.21.5 ICELL Latest Developments
11.22 SALIAI
11.22.1 SALIAI Company Information
11.22.2 SALIAI Adult Immune Cell Storage Product Offered
11.22.3 SALIAI Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.22.4 SALIAI Main Business Overview
11.22.5 SALIAI Latest Developments
11.23 S-Evans Biosciences
11.23.1 S-Evans Biosciences Company Information
11.23.2 S-Evans Biosciences Adult Immune Cell Storage Product Offered
11.23.3 S-Evans Biosciences Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.23.4 S-Evans Biosciences Main Business Overview
11.23.5 S-Evans Biosciences Latest Developments
11.24 Zhengda Stem Cell Bank
11.24.1 Zhengda Stem Cell Bank Company Information
11.24.2 Zhengda Stem Cell Bank Adult Immune Cell Storage Product Offered
11.24.3 Zhengda Stem Cell Bank Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.24.4 Zhengda Stem Cell Bank Main Business Overview
11.24.5 Zhengda Stem Cell Bank Latest Developments
11.25 Liaoning Huize Health Biotech
11.25.1 Liaoning Huize Health Biotech Company Information
11.25.2 Liaoning Huize Health Biotech Adult Immune Cell Storage Product Offered
11.25.3 Liaoning Huize Health Biotech Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.25.4 Liaoning Huize Health Biotech Main Business Overview
11.25.5 Liaoning Huize Health Biotech Latest Developments
11.26 Supercell Biotechnology
11.26.1 Supercell Biotechnology Company Information
11.26.2 Supercell Biotechnology Adult Immune Cell Storage Product Offered
11.26.3 Supercell Biotechnology Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.26.4 Supercell Biotechnology Main Business Overview
11.26.5 Supercell Biotechnology Latest Developments
11.27 Guangxi Academy of Sciences Cell Bank
11.27.1 Guangxi Academy of Sciences Cell Bank Company Information
11.27.2 Guangxi Academy of Sciences Cell Bank Adult Immune Cell Storage Product Offered
11.27.3 Guangxi Academy of Sciences Cell Bank Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.27.4 Guangxi Academy of Sciences Cell Bank Main Business Overview
11.27.5 Guangxi Academy of Sciences Cell Bank Latest Developments
11.28 Bailing Stem Cell
11.28.1 Bailing Stem Cell Company Information
11.28.2 Bailing Stem Cell Adult Immune Cell Storage Product Offered
11.28.3 Bailing Stem Cell Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.28.4 Bailing Stem Cell Main Business Overview
11.28.5 Bailing Stem Cell Latest Developments
11.29 Retain Biotech
11.29.1 Retain Biotech Company Information
11.29.2 Retain Biotech Adult Immune Cell Storage Product Offered
11.29.3 Retain Biotech Adult Immune Cell Storage Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.29.4 Retain Biotech Main Business Overview
11.29.5 Retain Biotech Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
